Search
for
Sort by
Research 841–870 of 1000+
- A Clinical Study on Cutaneous Manifestations of Obesity
- Adipose-Derived Stem Cells and Their Secretory Factors for Skin Aging and Hair Loss
- Hair growth control by follistatin
- Iron deficiency and diffuse nonscarring scalp alopecia in women: More pieces to the puzzle
- The patient outcomes with EGFR-mutated advanced non-small-cell lung cancer receiving aumolertinib as first-line treatment.
- Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Transarterial chemoembolization (TACE) combined with donafenib as first-line therapy for unresectable hepatocellular carcinoma (uHCC): A real-world clinical study.
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
- Adrenal myelolipoma: A rare entity
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- Protease-Activated Receptor-1 (Thrombin Receptor) Is Expressed in Mesenchymal Portions of Human Hair Follicle
- Epigen Transgenic Mice Develop Enlarged Sebaceous Glands
- Potential Consequences of the Use of Adipose-Derived Stem Cells in the Treatment of Hepatocellular Carcinoma
- Imatinib-induced classical lichen planopilaris in blaschko-linear distribution leading to cicatricial alopecia
- Dissecting the genetic variations associated with response to first-line chemotherapy in patients with small cell lung cancer: a retrospective cohort study
- <i>Gynostemma pentaphyllum</i> Makino extract induces hair growth and exhibits an anti‐graying effect via multiple mechanisms
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Current best evidence in pigmentary dermatology
- Multiple endocrine defects in adult-onset Sprouty1/2/4 triple knockout mice
- Retinoids Modulate MITF: A Novel Mechanism in the Regulation of Melanogenesis
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Sorafenib stimulates human skin type mast cell degranulation and maturation
- Synthetic Approaches for Pharmacologically Active Decorated Six-Membered Diazines
- Understanding autoimmunity of vitiligo and alopecia areata
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Neuregulin3 alters cell fate in the epidermis and mammary gland
- Non-Rash Skin Toxicities Associated with Novel Targeted Therapies